Menu
Back to Journals » Cancer Management and Research » Volume 12
Review
Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 19,184 | Dovepress* | 6,011+ | 1,105 | 7,116 | |
| PubMed Central* | 13,173 | 882 | 14,055 | ||
| Totals | 19,184 | 1,987 | 21,171 | ||
| *Since 23 June 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar